Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, Calidi Biotherapeutics Inc increased its cash reserves by 267.29%, or 1.58m. Cash Flow from Financing totalled 29.04m or -- of revenues. In addition the company used 26.98m for operations while cash used for investing totalled 478.00k.
Cash flow per share | -4.87 |
---|---|
Price/Cash flow per share | -- |
Book value per share | -1.82 |
---|---|
Tangible book value per share | -1.82 |
More ▼
Balance sheet in USDView more
Current ratio | 0.1245 |
---|---|
Quick ratio | -- |
Total debt/total equity | -- |
---|---|
Total debt/total capital | -- |
More ▼